NASDAQ: XBIO       Xenetic Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
0.866   -0.048 (5.25%)  0.82 - 0.98  218,024


Avg Volume (4 weeks):189,560
4 Weeks Range:0.82 - 1.07
4 Weeks Price Volatility (%):
52 Weeks Range:0.44 - 1.85
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company’s proprietary drug development platforms include PolyXen, which enables next-generation biologic drugs by improving their half-life and other pharmacological properties. The group’s product candidates include oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer (EC). The firm is based in the United States.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1653  4328  268  3150 

Top 10 Active Counters
 MGEN 1.235+0.715 
 TTNP 0.202+0.074 
 GE 7.69+0.59 
 LK 1.38+1.38 
 AAPL 112.66-3.94 
 SQQQ 24.255+2.195 
 OAS 0.155-0.014 
 NIO 27.489-0.951 
 NAKD 0.087-0.005 
 AMD 76.54-2.34